Ambrosino C, Cicatiello L, Cobellis G, Addeo R, Sica V, Bresciani F, Weisz A
Istituto di Patologia Generale e Oncologia, Prima Facoltà di Medicina e Chirurgia, Università di Napoli, Italy.
Mol Endocrinol. 1993 Nov;7(11):1472-83. doi: 10.1210/mend.7.11.8114761.
Estrogen hormones induce transient transcriptional activation of c-fos during the early phases of mitogenic stimulation of target cells. This is mediated by a functional estrogen response element (ERE) that in the human c-fos gene is localized 1kb up-stream of the transcription start site. This is the first known example of transient transcriptional activation induced by a steroid hormone acting via its nuclear receptor. Starting with the hypothesis that the product of c-fos (Fos) interferes with estrogen receptor (ER) activity on this gene promoter, generating in this way a feedback inhibition mechanism responsible for the rapid transcriptional down-regulation detected in vivo, we tested the effects of Fos overexpression on ER-mediated activation of the c-fos promoter in transfected HeLa cells. Transient transfection of an ER expression vector is followed by hormone-dependent trans-activation of reporter genes comprising the c-fos ERE linked to its own promoter. Coexpression of Fos in the cell induces a significant reduction in the activity of ER on the reporter genes. Fos antagonism is effective on both transcription activation functions of the receptor molecule and is independent of the nature of the target promoter. Furthermore, under the same experimental conditions, the estrogen-receptor complex antagonizes activation of an AP-1-responsive test gene by Fos. ER mutants deprived of the DNA-binding domain are efficient inhibitors of Fos activity, indicating that reciprocal antagonism is likely to be mediated by the formation of inactive complexes between the two factors. These results reveal the existence of a functional interference between the ER and Fos for regulation of c-fos protooncogene transcription. It is the first case in which the product of an estrogen-induced growth-related gene is shown to exert a negative feedback control on ER regulation of its own promoter.
雌激素在对靶细胞进行有丝分裂刺激的早期阶段,会诱导c-fos基因发生短暂的转录激活。这是由一个功能性雌激素反应元件(ERE)介导的,在人类c-fos基因中,该元件位于转录起始位点上游1kb处。这是已知的首个由类固醇激素通过其核受体作用诱导的短暂转录激活的例子。基于c-fos基因产物(Fos)会干扰雌激素受体(ER)对该基因启动子的活性这一假设,进而产生一种负责体内快速转录下调的反馈抑制机制,我们测试了Fos过表达对转染的HeLa细胞中ER介导的c-fos启动子激活的影响。瞬时转染ER表达载体后,会出现激素依赖性的对包含与自身启动子相连的c-fos ERE的报告基因的反式激活。在细胞中共表达Fos会导致ER对报告基因的活性显著降低。Fos拮抗作用对受体分子的两种转录激活功能均有效,且与靶启动子的性质无关。此外,在相同的实验条件下,雌激素受体复合物会拮抗Fos对AP-1反应性测试基因的激活。缺失DNA结合结构域的ER突变体是Fos活性的有效抑制剂,这表明相互拮抗作用可能是由这两种因子之间形成无活性复合物介导的。这些结果揭示了在c-fos原癌基因转录调控中,ER和Fos之间存在功能性干扰。这是首次证明雌激素诱导的生长相关基因产物对其自身启动子的ER调控发挥负反馈控制作用的情况。